Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg

被引：0

作者：

Yi-Han Chien

Gudrun Würthwein

Pablo Zubiaur

Bianca Posocco

María Ángeles Pena

Alberto M. Borobia

Sara Gagno

Francisco Abad-Santos

Georg Hempel

机构：

[1] Westfälische Wilhelms-Universität Münster,Clinical Pharmacology Department

[2] Institut für Pharmazeutische und Medizinische Chemie-Klinische Pharmazie,Experimental and Clinical Pharmacology Unit

[3] Hospital Universitario de la Princesa,Farmacología Clínica

[4] Pharmacology Department,Clinical Pharmacology Department

[5] Faculty of Medicine,undefined

[6] Universidad Autonoma de Madrid,undefined

[7] Instituto de Investigación Sanitaria la Princesa (IIS-Princesa),undefined

[8] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD),undefined

[9] Centro di Riferimento Oncologico di Aviano (CRO),undefined

[10] IRCCS,undefined

[11] Hospital Universitario Marqués de Valdecilla-Pabellón,undefined

[12] Hospital Universitario La Paz,undefined

[13] Pharmacology Department,undefined

[14] Faculty of Medicine,undefined

[15] Universidad Autonoma de Madrid,undefined

[16] IdiPAZ,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2022年 / 90卷

关键词：

Imatinib; Population pharmacokinetics; NONMEM; Ph + leukemia; Empirical Bayesian estimation; MAP Bayesian estimation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：125 / 136

页数：11

共 50 条

[31] Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects
Csajka, C
Haller, CA
Benowitz, NL
Verotta, D
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) : 335 - 345
[32] Anti-drug Antibodies in Normal Subjects Receiving a Single Dose of Intravenous Infliximab and Their Pharmacokinetic Effects
Ehrenpreis, Eli
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S389 - S390
[33] Evaluation of potential food effect on pharmacokinetic parameters of a single dose of 5 mg eplivanserin, a new sleep agent, administered orally to healthy subjects
Nougarede, M. D.
Clot, P. F.
Brunet, A.
SLEEP, 2008, 31 : A39 - A39
[34] Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects
Morgan, Roger E.
Campbell, Stuart E.
Yu, Christine Y.
Sponseller, Craig A.
Muster, Heather A.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (01) : 42 - 48
[35] Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease
Satyaprakash Nayak
Brinda Tammara
Lutz O. Harnisch
Drugs in R&D, 2021, 21 : 217 - 229
[36] Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease
Nayak, Satyaprakash
Tammara, Brinda
Harnisch, Lutz O.
DRUGS IN R&D, 2021, 21 (02) : 217 - 229
[37] Effect of Food on the Pharmacokinetics of a Single Oral Dose of Moxifloxacin 400mg in Healthy Male Volunteers
John Lettieri
Ramon Vargas
Vipin Agarwal
Patrick Liu
Clinical Pharmacokinetics, 2001, 40 : 19 - 25
[38] Concentrations of moxifloxacin (400 mg) in prostatic secretions and ejaculate after a single oral dose in healthy volunteers
Wagenlehner, F.
Kees, F.
Weidner, W.
Naber, K.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S383 - S384
[39] Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers
Stass, H
Sachse, R
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 71 - 76
[40] Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers
Lettieri, J
Vargas, R
Agarwal, V
Liu, P
CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 19 - 25

← 1 2 3 4 5 →